Risk Factors for Benign Breast Disease

Sponsor
Mansoura University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04127422
Collaborator
(none)
500
1
16.1
31.1

Study Details

Study Description

Brief Summary

Benign diseases of the breast are common clinical conditions that affect young women. Complaints related to the breast often cause significant discomfort and mental stress. The following study will try to identify the risk factors that may be associated with symptomatic benign breast diseases. Identification of such factors may help preventing and / or treating these conditions.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Benign breast disease (BBD) is a common cause of hospital visit. In young adults, benign breast conditions surpass cancer as a cause of symptoms related to the breast. However, breast symptoms may be associated with significant distress and may impose diagnostic difficulties. Moreover, certain pathological entities of benign breast conditions are well known to increase the risk of breast cancer.

    Identification of modifiable risk factors associated with symptomatic breast disorders has several potential benefits. Modification of such factors may help decrease patients' distress, hospital visits and indirectly decrease the risk of cancer.

    the available data point to the possible association of several environmental factors with symptomatic BBD. Most of the available information points to an association of BBD with anthropometric features, growth pattern, family history of breast conditions and dietary consumption. Substantial evidence are however lacking and further studies are strongly required to better characterize the risk factors of the condition.

    In this study, the investigators will systematically collect epidemiological, developmental and clinical data in young patients presenting with breast complaints. The association with disease incidence, pattern and histology will be examined.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Risk Factors for Benign Breast Disease in Young Adult Women. Case-control Study
    Actual Study Start Date :
    Nov 28, 2019
    Anticipated Primary Completion Date :
    Feb 1, 2021
    Anticipated Study Completion Date :
    Apr 1, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    Study group

    Patients presenting with current symptoms related to the breast. Adult females aged 18-39 years presenting to the breast outpatient clinic with either mastalgia, nodularity and/or discharge. A questionnaire, physical examination and bilateral breast ultrasonography will be obtained for all patients. A- The questionnaire will contain the following items: symptoms related to the breast. other medical history. menstrual history. obstetric history. rapid screener for beverages and fast food consumption. rapid screener for vegetables and fruit consumption. B- Physical examination will specifically records the following: breast tender point(s). breast nodularity. nipple discharge. weight, height, body mass index (BMI). C- bilateral breast ultrasonography for all patients. D- breast biopsy when clinically indicated as per hospital policy.

    Control group

    Age-matched healthy volunteers with no current medical conditions. Adult females aged 18-39 years with no current breast problems. These healthy volunteers will be asked to complete the same questionnaire as per the Study group and have anthropometric measure. A- The questionnaire will contain the following items: other medical history. menstrual history. obstetric history. rapid screener for beverages and fast food consumption. rapid screener for vegetables and fruit consumption. B- Physical examination will specifically records the following: 1- weight, height, body mass index (BMI).

    Outcome Measures

    Primary Outcome Measures

    1. Relative risk of benign breast disease associated with obesity. [This outcome will be assessed at baseline (the first hospital visit).]

      For the study and control groups, body mass index will be calculated as the weight (Kg) to square height (m) ratio.

    2. Relative risk of benign breast disease associated with soda beverage consumption. [This outcome will be assessed at baseline (the first hospital visit).]

      for the study and control groups, the participant will be asked about soda beverage consumption in the last 30 days. never consumed is scored 0 (lowest score). Three or more times a day is scored 9 (highest score).

    3. Relative risk of benign breast disease associated with caffeine beverages consumption. [This outcome will be assessed at baseline (the first hospital visit).]

      for the study and control groups, the participant will be asked about caffeine beverage consumption in the last 30 days. never consumed is scored 0 (lowest score). Three or more times a day is scored 9 (highest score).

    4. Relative risk of benign breast disease associated with parity. [This outcome will be assessed at baseline (the first hospital visit).]

      for the study and control groups, the participant will be asked about her parity. response will be either nullipara, primipara, multipara or grand multipara ( 5 or more births).

    Other Outcome Measures

    1. Relative risk of benign breast disease associated with hormonal contraception. [This outcome will be assessed at baseline (the first hospital visit).]

      for the study and control group, the participant will be asked about current hormonal contraception use.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 39 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • adult females with current symptoms related to the breast.
    Exclusion Criteria:
    • Current or past malignancy of the breast.

    • Discrete breast mass that necessitate work-up to exclude cancer.

    • Current psychiatric morbidity.

    • Persons unwilling to participate.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mansoura University Cancer center Mansoura Egypt 35516

    Sponsors and Collaborators

    • Mansoura University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Osama Hussein, Professor of Surgery, Mansoura University
    ClinicalTrials.gov Identifier:
    NCT04127422
    Other Study ID Numbers:
    • R.19.08.579
    First Posted:
    Oct 15, 2019
    Last Update Posted:
    Nov 19, 2020
    Last Verified:
    Nov 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Osama Hussein, Professor of Surgery, Mansoura University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 19, 2020